Trial Profile
Can metformin prevent endothelial ischemia and reperfusion injury? The Metformin-FMD trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Feb 2021
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Caffeine
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms Metformin-FMD
- 31 Aug 2013 Primary endpoint 'Flow-mediated-dilation' has not been met according to results presented at the 11th Congress of the European Association for Clinical Pharmacology and Therapeutics.
- 31 Aug 2013 Results presented at the 11th Congress of the European Association for Clinical Pharmacology and Therapeutics.
- 22 Feb 2012 New trial record